SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $366,000 | -62.3% | 20,400 | -50.2% | 0.19% | +70.2% |
| Q4 2019 | $972,000 | -2.7% | 41,000 | +1.5% | 0.11% | +40.7% |
| Q3 2016 | $999,000 | -53.3% | 40,400 | -74.6% | 0.08% | -70.2% |
| Q4 2015 | $2,138,000 | -4.1% | 159,100 | 0.0% | 0.27% | -6.2% |
| Q3 2015 | $2,230,000 | -32.6% | 159,100 | -18.4% | 0.29% | -37.2% |
| Q2 2015 | $3,307,000 | +64.7% | 194,900 | +17.2% | 0.46% | +65.0% |
| Q1 2015 | $2,008,000 | +145.5% | 166,300 | +68.8% | 0.28% | +104.4% |
| Q4 2014 | $818,000 | – | 98,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |